Discussion on three cases of retroperitoneal tumor involving great vessels by MDT mode under the aid of VR_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

LIU Tao , CHEN Kun ,  LI Wengang

Department of Hepatobiliary Surgery, School of Medicine of Xiamen University/Xiang’an Hospital of Xiamen University, Xiamen, Fujian 361102, P. R. China;

Corresponding?author：

LI Wengang, Email: lwg11861@163.com

Keywords：

retroperitoneal tumor; multidisciplinary team; virtual reality; three-dimensional visualization; individualized treatment

DOI：

10.7507/1007-9424.202009060

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To explore the application value of multidisciplinary collaborative team (MDT) model in retroperitoneal tumors involving large vessels.Methods Three cases of retroperitoneal tumors involving great vessels admitted to Xiang’an Hospital of Xiamen University in 2019 were retrospectively analyzed. With the support of 3D visual reconstruction and virtual reality (VR) technology, we performed MDT discussion and three cases received treatment of surgery, intervention, and targeted therapy.Results Case 1 was discussed by MDT and concluded that, based on CT examination, 3D reconstruction, and VR virtual image results, the tumor on the right side was determined to be completely resectable. The left tumor was judged to be unresectable, and the proposed treatment plan was right metastatic tumor resection + left metastatic tumor radiofrequency ablation. After surgery case 1 had been followed up for 6 months. The symptoms of diarrhea were significantly improved. CT reexamination showed that liver lesions and left retroperitoneal lesions were the same size and the condition was stable. After discussion by MDT, radiofrequency ablation around the tumor was proposed for case 2. This case was followed up for 3 months after surgery, and CT reexamination showed no new lesion in retroperitoneum. After MDT discussion, we concluded that arteriovenous fistula of case 3 had no indications for surgery, and proposed interventional combined with targeted therapy. After treatment, the tumor was found to be smaller after reexamination in 8 months than before treatment, and the efficacy was evaluated as partial remission. The follow-up was continued.Conclusion The future development trend of retroperitoneal tumor therapy involving great vessels is to evaluate each patient’s condition under the MDT mode by using 3D visual reconstruction and VR technology, and to formulate the individualized treatment plan of operation combined with other treatments.

Citation： LIU Tao, CHEN Kun, LI Wengang. Discussion on three cases of retroperitoneal tumor involving great vessels by MDT mode under the aid of VR. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2021, 28(5): 649-656. doi: 10.7507/1007-9424.202009060 Copy

1.	邱法波, 張圣林, 蔡亦軍, 等. 中國腹膜后腫瘤 10 年流行病學分析. 臨床普外科電子雜志, 2013, 1(1): 31-36.
2.	查立超, 李修霞, 周斌, 等. 原發性腹膜后肉瘤預后研究進展. 腹部外科, 2020, 33(4): 314-316, 331.
3.	曲騰飛, 何向陽, 周斌, 等. 腹膜后腫瘤手術入路及相關技巧. 中華普通外科雜志, 2020, 35(6): 499-501.
4.	羅成華, 苗成利. 腹膜后腫瘤的手術治療策略與新趨勢. 中國普外基礎與臨床雜志, 2016, 23(3): 257-259.
5.	白猛. VR 技術在手術教學中的應用. 福建電腦, 2020, 36(8): 135-136.
6.	Tzanis D, Bouhadiba T, Gaignard E, et al. Major vascular resections in retroperitoneal sarcoma. J Surg Oncol, 2018, 117(1): 42-47.
7.	中華醫學會數字醫學分會, 中國研究型醫院學會數字醫學臨床外科專業委員會. 腹膜后腫瘤三維可視化精準診治專家共識 (2018 版). 中國實用外科雜志, 2018, 38(12): 1347-1353.
8.	韓善清, 房加高, 陳愛萍, 等. 基于三維可視化技術的后腹膜腫瘤精準手術切除. 中國數字醫學, 2020, 15(1): 58-60.
9.	盧家俊, 施云濤, 史向軍, 等. 三維可視化技術在腹膜后腫瘤切除術中應用研究. 中國實用外科雜志, 2019, 39(9): 959-963.
10.	李菲菲. 基于 VR 技術的 3D 手術操作練習模擬器的設計與開發. 科技創新與應用, 2020, (16): 40-42.
11.	Czeyda-Pommersheim F, Menias C, Boustani A, et al. Diagnostic approach to primary retroperitoneal pathologies: what the radiologist needs to know. Abdom Radiol (NY), 2020, [Online ahead of print].
12.	Sugiyama T, Clapp T, Nelson J, et la. Immersive 3-Dimensional virtual reality modeling for case-specific presurgical discussions in cerebrovascular neurosurgery. Oper Neurosurg (Hagerstown), 2020, [Online ahead of print].
13.	Lungu AJ, Swinkels W, Claesen L, et al. A review on the applications of virtual reality, augmented reality and mixed reality in surgical simulation: an extension to different kinds of surgery. Expert Rev Med Devices, 2020, [Online ahead of print].
14.	Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1 007 patients from the Multi-Institutional Collaborative RPS Working Group. Ann Surg, 2016, 263(5): 1002-1009.
15.	MacNeill AJ, Miceli R, Strauss DC, et al. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group. Cancer, 2017, 123(11): 1971-1978.
16.	Zaidi MY, Canter R, Cardona K. Post-operative surveillance in retroperitoneal soft tissue sarcoma: The importance of tumor histology in guiding strategy. J Surg Oncol, 2018, 117(1): 99-104.
17.	Murez T, Fléchon A, Rocher L, et al. CCAFU french national guidelines 2016-2018 on retroperitoneal sarcoma. Prog Urol, 2016, 27 Suppl 1: S183-S190.
18.	Hamilton TD, Cannell AJ, Kim M, et al. Results of resection for recurrent or residual retroperitoneal sarcoma after failed primary treatment. Ann Surg Oncol, 2017, 24(1): 211-218.
19.	李紅麗, 郭占濤. 虛擬現實技術的應用及其不足. 信息通信, 2018, (12): 255-257.
20.	郭娜, 王田苗, 胡磊, 等. ACL 重建手術增強現實導航系統的人機交互技術. 計算機工程與應用, 2020, 56(21): 224-230.
21.	李寧, 曹志強. 增強現實、混合現實在泌尿外科導航手術中的應用. 中華腔鏡泌尿外科雜志 (電子版), 2020, 14(4): 241-245.
22.	Bremjit PJ, Jones RL, Chai X, et al. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma. Ann Surg Oncol, 2014, 21(7): 2150-2158.
23.	von Mehren M, Randall RL, Benjamin RS, et al. Soft Tissue Sarcoma, Version 2. 2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 2018, 16(5): 536-563.
24.	趙紀春, 陳熹陽. 累及大血管的腹膜后腫瘤的手術治療. 中國普外基礎與臨床雜志, 2016, 23(3): 260-262.
25.	中華醫學會外科學分會外科手術學學組, 中國抗癌協會肉瘤專業委員會, 中國醫療保健國際交流促進會軟組織腫瘤分會, 等. 原發性腹膜后軟組織肉瘤診治中國專家共識 (2019 版). 中國實用外科雜志, 2019, 39(6): 526-532.

1. 邱法波, 張圣林, 蔡亦軍, 等. 中國腹膜后腫瘤 10 年流行病學分析. 臨床普外科電子雜志, 2013, 1(1): 31-36.
2. 查立超, 李修霞, 周斌, 等. 原發性腹膜后肉瘤預后研究進展. 腹部外科, 2020, 33(4): 314-316, 331.
3. 曲騰飛, 何向陽, 周斌, 等. 腹膜后腫瘤手術入路及相關技巧. 中華普通外科雜志, 2020, 35(6): 499-501.
4. 羅成華, 苗成利. 腹膜后腫瘤的手術治療策略與新趨勢. 中國普外基礎與臨床雜志, 2016, 23(3): 257-259.
5. 白猛. VR 技術在手術教學中的應用. 福建電腦, 2020, 36(8): 135-136.
6. Tzanis D, Bouhadiba T, Gaignard E, et al. Major vascular resections in retroperitoneal sarcoma. J Surg Oncol, 2018, 117(1): 42-47.
7. 中華醫學會數字醫學分會, 中國研究型醫院學會數字醫學臨床外科專業委員會. 腹膜后腫瘤三維可視化精準診治專家共識 (2018 版). 中國實用外科雜志, 2018, 38(12): 1347-1353.
8. 韓善清, 房加高, 陳愛萍, 等. 基于三維可視化技術的后腹膜腫瘤精準手術切除. 中國數字醫學, 2020, 15(1): 58-60.
9. 盧家俊, 施云濤, 史向軍, 等. 三維可視化技術在腹膜后腫瘤切除術中應用研究. 中國實用外科雜志, 2019, 39(9): 959-963.
10. 李菲菲. 基于 VR 技術的 3D 手術操作練習模擬器的設計與開發. 科技創新與應用, 2020, (16): 40-42.
11. Czeyda-Pommersheim F, Menias C, Boustani A, et al. Diagnostic approach to primary retroperitoneal pathologies: what the radiologist needs to know. Abdom Radiol (NY), 2020, [Online ahead of print].
12. Sugiyama T, Clapp T, Nelson J, et la. Immersive 3-Dimensional virtual reality modeling for case-specific presurgical discussions in cerebrovascular neurosurgery. Oper Neurosurg (Hagerstown), 2020, [Online ahead of print].
13. Lungu AJ, Swinkels W, Claesen L, et al. A review on the applications of virtual reality, augmented reality and mixed reality in surgical simulation: an extension to different kinds of surgery. Expert Rev Med Devices, 2020, [Online ahead of print].
14. Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1 007 patients from the Multi-Institutional Collaborative RPS Working Group. Ann Surg, 2016, 263(5): 1002-1009.
15. MacNeill AJ, Miceli R, Strauss DC, et al. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group. Cancer, 2017, 123(11): 1971-1978.
16. Zaidi MY, Canter R, Cardona K. Post-operative surveillance in retroperitoneal soft tissue sarcoma: The importance of tumor histology in guiding strategy. J Surg Oncol, 2018, 117(1): 99-104.
17. Murez T, Fléchon A, Rocher L, et al. CCAFU french national guidelines 2016-2018 on retroperitoneal sarcoma. Prog Urol, 2016, 27 Suppl 1: S183-S190.
18. Hamilton TD, Cannell AJ, Kim M, et al. Results of resection for recurrent or residual retroperitoneal sarcoma after failed primary treatment. Ann Surg Oncol, 2017, 24(1): 211-218.
19. 李紅麗, 郭占濤. 虛擬現實技術的應用及其不足. 信息通信, 2018, (12): 255-257.
20. 郭娜, 王田苗, 胡磊, 等. ACL 重建手術增強現實導航系統的人機交互技術. 計算機工程與應用, 2020, 56(21): 224-230.
21. 李寧, 曹志強. 增強現實、混合現實在泌尿外科導航手術中的應用. 中華腔鏡泌尿外科雜志 (電子版), 2020, 14(4): 241-245.
22. Bremjit PJ, Jones RL, Chai X, et al. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma. Ann Surg Oncol, 2014, 21(7): 2150-2158.
23. von Mehren M, Randall RL, Benjamin RS, et al. Soft Tissue Sarcoma, Version 2. 2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 2018, 16(5): 536-563.
24. 趙紀春, 陳熹陽. 累及大血管的腹膜后腫瘤的手術治療. 中國普外基礎與臨床雜志, 2016, 23(3): 260-262.
25. 中華醫學會外科學分會外科手術學學組, 中國抗癌協會肉瘤專業委員會, 中國醫療保健國際交流促進會軟組織腫瘤分會, 等. 原發性腹膜后軟組織肉瘤診治中國專家共識 (2019 版). 中國實用外科雜志, 2019, 39(6): 526-532.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Discussion on three cases of retroperitoneal tumor involving great vessels by MDT mode under the aid of VR

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content